393 related articles for article (PubMed ID: 20375184)
1. Progesterone is essential for maintenance and growth of uterine leiomyoma.
Ishikawa H; Ishi K; Serna VA; Kakazu R; Bulun SE; Kurita T
Endocrinology; 2010 Jun; 151(6):2433-42. PubMed ID: 20375184
[TBL] [Abstract][Full Text] [Related]
2. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
3. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
4. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
5. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
6. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma.
Matsuo H; Kurachi O; Shimomura Y; Samoto T; Maruo T
Oncology; 1999 Oct; 57 Suppl 2():49-58. PubMed ID: 10545803
[TBL] [Abstract][Full Text] [Related]
7. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.
Severino MF; Murray MJ; Brandon DD; Clinton GM; Burry KA; Novy MJ
Mol Hum Reprod; 1996 Nov; 2(11):823-8. PubMed ID: 9237221
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Hormonal Impact of a Mouse Xenograft Model for Human Uterine Leiomyoma.
Malik M; Britten J; Catherino WH
Reprod Sci; 2020 Jun; 27(6):1304-1317. PubMed ID: 32016804
[TBL] [Abstract][Full Text] [Related]
9. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
Yamada T; Nakago S; Kurachi O; Wang J; Takekida S; Matsuo H; Maruo T
Hum Reprod; 2004 Apr; 19(4):815-21. PubMed ID: 15033949
[TBL] [Abstract][Full Text] [Related]
10. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.
Cramer SF; Robertson AL; Ziats NP; Pearson OH
Obstet Gynecol; 1985 Jul; 66(1):36-41. PubMed ID: 3892387
[TBL] [Abstract][Full Text] [Related]
11. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.
Gueye NA; Mead TJ; Koch CD; Biscotti CV; Falcone T; Apte SS
J Clin Endocrinol Metab; 2017 May; 102(5):1631-1641. PubMed ID: 28323982
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.
Yin P; Roqueiro D; Huang L; Owen JK; Xie A; Navarro A; Monsivais D; Coon JS; Kim JJ; Dai Y; Bulun SE
PLoS One; 2012; 7(1):e29021. PubMed ID: 22272226
[TBL] [Abstract][Full Text] [Related]
13. Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
Bulun SE; Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Zhao H; Maruyama T; Chakravarti D; Kim JJ; Wei JJ
Semin Reprod Med; 2015 Sep; 33(5):357-65. PubMed ID: 26251118
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of latent TGF-beta binding protein-1 and fibrillin-1 in human uterine leiomyomata.
Zhao Y; Wen Y; Polan ML; Qiao J; Chen BH
Mol Hum Reprod; 2007 May; 13(5):343-9. PubMed ID: 17360930
[TBL] [Abstract][Full Text] [Related]
15. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
Yoshida S; Ohara N; Xu Q; Chen W; Wang J; Nakabayashi K; Sasaki H; Morikawa A; Maruo T
Semin Reprod Med; 2010 May; 28(3):260-73. PubMed ID: 20414849
[TBL] [Abstract][Full Text] [Related]
16. Estradiol and progesterone binding in uterine leiomyomata and pregnant myometrium.
Nardelli GB; Mega M; Bertasi M; Siliotti F
Clin Exp Obstet Gynecol; 1987; 14(3-4):155-60. PubMed ID: 3454723
[TBL] [Abstract][Full Text] [Related]
17. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
Sampath D; Zhu Y; Winneker RC; Zhang Z
J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
[TBL] [Abstract][Full Text] [Related]
19. LAT1 regulates growth of uterine leiomyoma smooth muscle cells.
Xia Luo ; Coon JS; Su E; Pearson EK; Ping Yin ; Ishikawa H; Bulun SE
Reprod Sci; 2010 Sep; 17(9):791-7. PubMed ID: 20601542
[TBL] [Abstract][Full Text] [Related]
20. Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some Properties of Myometrial Cells Cultured under Serum Deprivation Conditions in the Presence of Ovarian Steroids.
Bonazza C; Andrade SS; Sumikawa JT; Batista FP; Paredes-Gamero EJ; Girão MJ; Oliva ML; Castro RA
PLoS One; 2016; 11(7):e0158578. PubMed ID: 27391384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
